Acute Porphyria Drugs

Monograph

J01XA01 - Vancomycin
Not porphyrinogenic
NP

Rationale
Polycyclic glycopeptide, in greater parts not metabolised. Several references state non- porphyrinogenicity.
Chemical description
Polycyclic glycopeptide antibiotic produced by Streptomyces orientalis, used in severe multiresistent infections. 70-80% of the drug is excreted by the kidneys in unchanged form within 24 hours. EPI-list: safe. South African list: use. French list: use. Australian list: use. Hift et al. Br J. Pharamcol 1990; 29:273-55: no ill effect.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J01X / J01XA or go back.
References
Tradenames

Vancomycin · Vancomycine Vancomycin · Vancomycine Vancomicina Vancocin · Vancomycin · Vancomycin-Human Vancomicina Vancocin · Vancomycin Vancocin · Vancomycin Bactocin · Vancomycin Vancomycin Edicin · Vancomycin · Vancomycinum Vancomycin · Vancomycine Vancomycin Vancomycin · Vancosan Vancomicina · Vancomycin · Vancosan Vancosan Edicin · Vancomycin · Vancosan Vancomycin · Vondem · Voxin Edicin · Vancocin · Vancoled · Vancomycin · Vankomicin · Vankomicinijev
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙